[go: up one dir, main page]

JPH0572907B2 - - Google Patents

Info

Publication number
JPH0572907B2
JPH0572907B2 JP85287601A JP28760185A JPH0572907B2 JP H0572907 B2 JPH0572907 B2 JP H0572907B2 JP 85287601 A JP85287601 A JP 85287601A JP 28760185 A JP28760185 A JP 28760185A JP H0572907 B2 JPH0572907 B2 JP H0572907B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
tetrahydro
benzthiazole
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP85287601A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61155377A (ja
Inventor
Gurisu Geruharuto
Sukunaidaa Kurausu
Furunausu Rudorufu
Kobingaa Barutaa
Pihiraa Rudoitsugu
Bauaa Rudorufu
Mierau Yoahimu
Hinzen Deietaa
Sukingunitsutsu Gyuntaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of JPS61155377A publication Critical patent/JPS61155377A/ja
Publication of JPH0572907B2 publication Critical patent/JPH0572907B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP60287601A 1984-12-22 1985-12-20 テトラヒドロ‐ベンズチアゾール化合物およびその製造方法 Granted JPS61155377A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3447075.1 1984-12-22
DE19843447075 DE3447075A1 (de) 1984-12-22 1984-12-22 Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
DE3508947.4 1985-03-13

Publications (2)

Publication Number Publication Date
JPS61155377A JPS61155377A (ja) 1986-07-15
JPH0572907B2 true JPH0572907B2 (de) 1993-10-13

Family

ID=6253655

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60287601A Granted JPS61155377A (ja) 1984-12-22 1985-12-20 テトラヒドロ‐ベンズチアゾール化合物およびその製造方法

Country Status (5)

Country Link
JP (1) JPS61155377A (de)
BR (1) BR1100678A (de)
DD (1) DD242230A5 (de)
DE (1) DE3447075A1 (de)
ZA (1) ZA859731B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008140051A1 (ja) 2007-05-11 2008-11-20 Santen Pharmaceutical Co., Ltd. 非麦角系の選択的ｄ２受容体アゴニストを有効成分として含有する後眼部疾患の予防又は治療剤

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3620813A1 (de) * 1986-06-21 1987-12-23 Boehringer Ingelheim Kg Neue tetrahydro-benzothiazole, ihre herstellung und verwendung
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
SE9802360D0 (sv) * 1998-07-01 1998-07-01 Wikstroem Hakan Vilhelm New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins ((basic)-N-substituted and (basic)-N,N-disubstituted derivatives of 2,6-diamino-thiazolo(4,5-f)indan and 2,7-di-amino-thiazolo(4,5-g)tetralin
US6277875B1 (en) * 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
WO2003049705A2 (en) * 2001-12-11 2003-06-19 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
US20070196481A1 (en) * 2002-07-25 2007-08-23 Amidon Gregory E Sustained-release tablet composition
US20050226926A1 (en) * 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
GB2394951A (en) * 2002-11-04 2004-05-12 Cipla Ltd One pot synthesis of 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole
DE102004006808A1 (de) * 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
ATE496036T1 (de) * 2004-03-19 2011-02-15 Dipharma Francis Srl Zwischenprodukte für die herstellung von pramipexol
ES2245604B1 (es) * 2004-06-25 2006-12-01 Ragactives, S. L. Procedimiento para la obtencion de 2-amino-6-alquil-amino-4,5,6,7-tetrahidrobenzotiazoles.
ES2264378B1 (es) * 2005-05-09 2007-11-01 Ragactives, S.L. Procedimiento para la resolucion de 2-amino-6propilamino-4,5,6,7-tetrahidrobenzotiazol y compuestos intermedios.
US8519148B2 (en) * 2007-03-14 2013-08-27 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
CN102186350A (zh) 2008-08-19 2011-09-14 诺普神经科学股份有限公司 使用(r)-普拉克索的组合物与方法
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
WO2015023786A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
PT3033081T (pt) 2013-08-13 2021-06-01 Knopp Biosciences Llc Composições e métodos para o tratamento da urticária crónica

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008140051A1 (ja) 2007-05-11 2008-11-20 Santen Pharmaceutical Co., Ltd. 非麦角系の選択的ｄ２受容体アゴニストを有効成分として含有する後眼部疾患の予防又は治療剤

Also Published As

Publication number Publication date
DE3447075A1 (de) 1986-07-03
ZA859731B (en) 1987-08-26
DD242230A5 (de) 1987-01-21
JPS61155377A (ja) 1986-07-15
BR1100678A (pt) 1999-10-13

Similar Documents

Publication Publication Date Title
KR930009791B1 (ko) 테트라하이드로-벤즈티아졸의제조방법
JPH0572907B2 (de)
SK31793A3 (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines and piperazines and compositions and methods of use thereof
CN105367565B (zh) 哌嗪(啶)环己基衍生物及其治疗精神神经疾病的应用
IE913940A1 (en) 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
CZ8297A3 (en) Benzamidine, process of its preparation and pharmaceutical compositions containing thereof
EP0409048B1 (de) Aminoalkylsubstituierte 2-Aminothiazole und diese enthaltende therapeutische Mittel
JP2705788B2 (ja) 新規な、アミノアルキルベンゾオキサゾリノン及びベンゾチアゾリノン、それらの製造方法及びそれらを含有する製薬学的組成物
JPH10139780A (ja) 新規な複素環式アミノメチル化合物、これらの製造方法及びこれらを含む医薬組成物
JP2002538117A (ja) 肥満の予防または治療のための医薬の製造のための多環２−アミノチアゾール系の使用
US3177211A (en) 10-[(aminocarbamyl-1-piperidyl)-loweralkyl]-phenothiazines
JPS584715B2 (ja) 新規なアリ−ルトリフルオロエチルアミン
JP4426572B2 (ja) ベンゾチアゾール誘導体、およびアデノシンａ２ａ受容体に関連した疾患の処置でのその使用
CN112047962B (zh) 2H-噻唑并[3,2-b]-1,2,4-三嗪-3,7-二酮类衍生物及应用
CZ20013365A3 (cs) Morfolinové deriváty, způsob jejich přípravy a farmaceutické prostředky obsahující tyto sloučeniny
EP0703232A2 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
EP0397169B1 (de) Benzothiazol-Derivate
RU2602504C1 (ru) Гидрогалогениды 11-[(4-трет-бутилфенокси)этил]- и 11-бензилзамещённых 2,3,4,5-тетрагидро[1,3]диазепино[1,2-a]бензимидазола, обладающие альфа-глюкозидаза ингибирующей активностью
JPS6311353B2 (de)
JPS63233972A (ja) 新規なインドールカルボキサミド誘導体及びその塩類、それらの製造法及び中間体、これら誘導体の医薬品への使用並びにそれらを含有する組成物
KR101459720B1 (ko) 세로토닌 5-ＨＴ6 저해 활성을 갖는 5-설포닐아미노-5,6-다이하이드로-1Ｈ-피라졸로[3,4-ｃ]피리딘-7(4Ｈ)-온 화합물
DE3508947A1 (de) Mittel zur behandlung des parkinsonismus bzw. der parkinsonschen-erkrankung
JP2000504305A (ja) Ｈ▲下２▼受容体拮抗剤としての（４−（３−アミノメチルフェニル）チアゾール−２−イル）グアニジン類
JPS61251676A (ja) 新規トリメトキシベンジルピペラジン誘導体および該化合物を有効成分とする医薬組成物
JP2000515117A (ja) 置換６―ｒ―１，３，４―チアジアジン―２―アミン、麻酔剤、心臓血管剤および代謝低下剤としてのそれらの使用、およびそれらを含有する医薬組成物

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081013

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081013

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091013

Year of fee payment: 16

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091013

Year of fee payment: 16

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101013

Year of fee payment: 17

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101013

Year of fee payment: 17

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111013

Year of fee payment: 18

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111013

Year of fee payment: 18